These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 28008454)

  • 21. Accurate prediction of responses to transarterial chemoembolization for patients with hepatocellular carcinoma by using artificial intelligence in contrast-enhanced ultrasound.
    Liu D; Liu F; Xie X; Su L; Liu M; Xie X; Kuang M; Huang G; Wang Y; Zhou H; Wang K; Lin M; Tian J
    Eur Radiol; 2020 Apr; 30(4):2365-2376. PubMed ID: 31900703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative analysis of microcirculation blood perfusion in patients with hepatocellular carcinoma before and after transcatheter arterial chemoembolisation using contrast-enhanced ultrasound.
    Tian H; Wang Q
    Eur J Cancer; 2016 Nov; 68():82-89. PubMed ID: 27728840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor Vascular Networks Depicted in Contrast-Enhanced Ultrasound Images as a Predictor for Transarterial Chemoembolization Treatment Response.
    Oezdemir I; Wessner CE; Shaw C; Eisenbrey JR; Hoyt K
    Ultrasound Med Biol; 2020 Sep; 46(9):2276-2286. PubMed ID: 32561069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computed Tomography Perfusion Following Transarterial Chemoembolization of Hepatocellular Carcinoma: A Feasibility Study in the Early Period.
    Wimmer T; Steiner J; Talakic E; Stauber R; Quehenberger F; Portugaller RH; Schoellnast H
    J Comput Assist Tomogr; 2017; 41(5):708-712. PubMed ID: 28296685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and evaluation of an ultrasound-triggered microbubble combined transarterial chemoembolization (TACE) formulation on rabbit VX2 liver cancer model.
    Kim D; Lee JH; Moon H; Seo M; Han H; Yoo H; Seo H; Lee J; Hong S; Kim P; Lee HJ; Chung JW; Kim H
    Theranostics; 2021; 11(1):79-92. PubMed ID: 33391462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative evaluation of CT-perfusion map as indicator of tumor response to transarterial chemoembolization and radiofrequency ablation in HCC patients.
    Ippolito D; Fior D; Bonaffini PA; Capraro C; Leni D; Corso R; Sironi S
    Eur J Radiol; 2014 Sep; 83(9):1665-71. PubMed ID: 24962900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of treatment response after chemoembolisation (TACE) in hepatocellular carcinoma using real time image fusion of contrast-enhanced ultrasound (CEUS) and computed tomography (CT)--preliminary results.
    Wobser H; Wiest R; Salzberger B; Wohlgemuth WA; Stroszczynski C; Jung EM
    Clin Hemorheol Microcirc; 2014; 57(2):191-201. PubMed ID: 24577382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contrast-Enhanced Ultrasonography Versus Contrast-Enhanced Computed Tomography for Assessment of Residual Tumor From Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: A Meta-analysis.
    Zhong J; Su Z; Zhang Y; Zhang H; Lin P; Tang X; Zheng R
    J Ultrasound Med; 2018 Aug; 37(8):1881-1890. PubMed ID: 29380404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. mRECIST criteria and contrast-enhanced US for the assessment of the response of hepatocellular carcinoma to transarterial chemoembolization.
    Moschouris H; Malagari K; Papadaki MG; Kornezos I; Stamatiou K; Anagnostopoulos A; Chatzimichael K; Kelekis N
    Diagn Interv Radiol; 2014; 20(2):136-42. PubMed ID: 24317334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early evaluation of treatment response to transarterial chemoembolization in patients with advanced hepatocellular carcinoma: The role of dynamic three-dimensional contrast-enhanced ultrasound.
    Cao J; Dong Y; Fan P; Mao F; Chen K; Chen R; Huang B; Cheng Y; Wang WP
    Clin Hemorheol Microcirc; 2021; 78(4):365-377. PubMed ID: 33682701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Degradable starch microspheres transarterial chemoembolisation (DSM-TACE) of HCC: Dynamic Contrast-Enhanced Ultrasonography (DCE-US) based evaluation of therapeutic efficacy using a novel perfusion software.
    Wiggermann P; Heibl M; Niessen C; Müller-Wille R; Gössmann H; Uller W; Poschenrieder F; Schreyer AG; Wohlgemuth WA; Stroszczynski C; Jung EM
    Clin Hemorheol Microcirc; 2012; 52(2-4):123-9. PubMed ID: 22960293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contrast-Enhanced Ultrasound and Computed Tomography Assessment of Hepatocellular Carcinoma after Transcatheter Arterial Chemo-Embolization: A Systematic Review.
    Tai CJ; Huang MT; Wu CH; Tai CJ; Shi YC; Chang CC; Chang YJ; Kuo LJ; Wei PL; Chen RJ; Chiou HY
    J Gastrointestin Liver Dis; 2016 Dec; 25(4):499-507. PubMed ID: 27981306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic arterial damage after transarterial chemoembolization for the treatment of hepatocellular carcinoma: comparison of drug-eluting bead and conventional chemoembolization in a retrospective controlled study.
    Lee S; Kim KM; Lee SJ; Lee KH; Lee DY; Kim MD; Kim DY; Kim SU; Won JY
    Acta Radiol; 2017 Feb; 58(2):131-139. PubMed ID: 27217418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of percutaneous ultrasound-guided treatment for ultrasonically invisible hypervascular hepatocellular carcinoma using microbubble contrast agent.
    Maruyama H; Kobayashi S; Yoshizumi H; Okugawa H; Akiike T; Yukisawa S; Fukuda H; Matsutani S; Ebara M; Saisho H
    Clin Radiol; 2007 Jul; 62(7):668-75. PubMed ID: 17556036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contrast-enhanced ultrasound as a predictor of treatment efficacy within 2 weeks after transarterial chemoembolization of hepatocellular carcinoma.
    Kono Y; Lucidarme O; Choi SH; Rose SC; Hassanein TI; Alpert E; Mattrey RF
    J Vasc Interv Radiol; 2007 Jan; 18(1 Pt 1):57-65. PubMed ID: 17296705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of posttreatment response of hepatocellular carcinoma: comparison of ultrasonography with second-generation ultrasound contrast agent and multidetector CT.
    Salvaggio G; Campisi A; Lo Greco V; Cannella I; Meloni MF; Caruso G
    Abdom Imaging; 2010 Aug; 35(4):447-53. PubMed ID: 19562414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Volume perfusion computed tomography (VPCT)-based evaluation of response to TACE using two different sized drug eluting beads in patients with nonresectable hepatocellular carcinoma: Impact on tumor and liver parenchymal vascularisation.
    Kaufmann S; Horger T; Oelker A; Beck S; Schulze M; Nikolaou K; Ketelsen D; Horger M
    Eur J Radiol; 2015 Dec; 84(12):2548-54. PubMed ID: 26428842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transarterial chemoembolization for hepatocellular carcinoma: significance of extrahepatic collateral supply.
    Paul SB; Gamanagatti SR; Mukund A; Abbas SZ; Acharya SK
    Indian J Cancer; 2011; 48(3):339-44. PubMed ID: 21921335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microvascular Flow Imaging of Residual or Recurrent Hepatocellular Carcinoma after Transarterial Chemoembolization: Comparison with Color/Power Doppler Imaging.
    Kang HJ; Lee JM; Jeon SK; Ryu H; Yoo J; Lee JK; Han JK
    Korean J Radiol; 2019 Jul; 20(7):1114-1123. PubMed ID: 31270975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamic Contrast-Enhanced Magnetic Resonance Imaging With Gadolinium Ethoxybenzyl Diethylenetriamine Pentaacetic Acid for Quantitative Assessment of Vascular Effects on Hepatocellular-Carcinoma Lesions Treated by Transarterial Chemoembolization or Radiofrequency Ablation.
    Ippolito D; Trattenero C; Talei Franzesi C; Casiraghi A; Lombardi S; Vacirca F; Corso R; Sironi S
    J Comput Assist Tomogr; 2016; 40(5):692-700. PubMed ID: 27560010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.